[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-341651-105":59,"doc-detail-341651-en":134},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":127,"head_meta":129,"extra_data":131,"updated_unix":133},105,"en","investigating-radiotherapy-effects-on-pd-l1-expression-in-circulating-tumor-cells-an-exploratory-study","Investigating Radiotherapy Effects on PD-L1 Expression in Circulating Tumor Cells - An Exploratory Study","","Circulating tumor cells (CTCs) and PD-L1 are central to cancer biology and treatment response. This exploratory prospective cohort study assessed whether neoadjuvant radiotherapy alters PD-L1 expression in tumor tissues and CTCs in 27 patients with inoperable locally advanced breast cancer. Biopsies and blood samples were collected before and after the tenth radiotherapy fraction, with CTC enrichment and RT-PCR analysis for PD-L1. Radiotherapy produced no significant PD-L1 changes in tissues or CTCs, though baseline tissue PD-L1 associated with RECIST outcomes.",{"@graph":69,"@context":126},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/investigating-radiotherapy-effects-on-pd-l1-expression-in-circulating-tumor-cells-an-exploratory-study/341651/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/investigating-radiotherapy-effects-on-pd-l1-expression-in-circulating-tumor-cells-an-exploratory-study/341651.png","ImageObject",300,407,{"name":92,"@type":93},"Asher","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-31","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118,122],{"name":109,"@type":110,"acceptedAnswer":111},"What was the primary aim of this exploratory study?","Question",{"text":112,"@type":113},"To determine whether neoadjuvant radiotherapy influences PD-L1 expression in tumor tissues and circulating tumor cells in patients with inoperable locally advanced breast cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were CTCs isolated and PD-L1 measured?",{"text":117,"@type":113},"CTCs were enriched using magnetic beads, followed by RT-PCR analysis to assess PD-L1 expression.",{"name":119,"@type":110,"acceptedAnswer":120},"Did neoadjuvant radiotherapy significantly change PD-L1 expression?",{"text":121,"@type":113},"No. The study found no significant alterations in PD-L1 expression in either tumor tissues or CTCs during radiotherapy.",{"name":123,"@type":110,"acceptedAnswer":124},"What association was observed with RECIST?",{"text":125,"@type":113},"PD-L1 expression in tumor tissue before treatment was significantly associated with RECIST criteria.","https://schema.org",{"og:url":83,"og:type":128,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":130,"canonical":83},"index,follow",{"doc_id":132,"site_id":62},341651,1790143474,{"code":4,"msg":5,"data":135},{"doc_id":132,"user_id":136,"nickname":92,"user_avatar":137,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":138,"file_id":139,"file_url":140,"file_type":141,"file_size":142,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":39,"language":143,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":144,"faqs":145,"seo_title":146,"seo_description":67,"update_tm":147,"read_time":46,"preview_page_count":19,"preview_urls":148},687197207639,"https://ap-avatar.wpscdn.com/davatar_a8503ba1806abce46bf441b54a3ca4cd","RESEARCH ARTICLE  \nEditorial Process: Submission:09/17/2023 Acceptance:05/03/2024  \nInvestigating Radiotherapy Effects on PD-L1 Expression in Circulating Tumor Cells: An Exploratory Study  \nRhandyka Rafli1, Wirsma Arif Harahap2 *, Soehartati Gondhowiardjo3, Andani Ekaputra2  \nAbstract  \nIntroduction: Circulating tumor cells (CTCs) and Programmed death-ligand 1 (PD-L1) play pivotal roles in cancer biology and therapy response. This exploratory study aimed to elucidate the influence of neoadjuvant radiotherapy on PD-L1 expression in tumor tissues and CTCs of patients with inoperable locally advanced breast cancer. Methods: We conducted a prospective cohort study at Universitas Andalas Hospital Padang from January to December 2022 with 27 patients. Biopsies and blood draws were executed before and after the tenth fractions of neoadjuvant radiotherapy. Following radiotherapy, CTCs were isolated using magnetic beads enrichment, followed by an RT-PCR analysis for PD-L1 expression. Correlations between PD-L1 expression and tumor response, evaluated via local response and RECIST criteria before and after radiotherapy breast CT scan, were examined using Fisher’s exact and chi-square tests. Results: Our data revealed no significant alterations in PD-L1 expression in either tumor tissues or CTCs during radiotherapy (p=0.848 for tissue, p=0.548 for CTCs). Notably, PD-L1 expression in tumor tissue before treatment was significantly associated with RECIST (p=0.021), while other correlations with local response and RECIST were not statistically significant. Conclusion: The study implies radiotherapy may not significantly influence PD-L1 expression in tumor tissue and CTCs. However, pre-treatment PD-L1 expression in tumor tissue correlates with RECIST criteria. These findings highlight the need for additional, comprehensive studies to elucidate further the interplay between PDL1, CTCs, and radiotherapy response.  \nKeywords: Circulating Tumor Cells (CTCs)-PD-L1-neoadjuvant radiotherapy-locally advanced breast cancer  \nAsian Pac J Cancer Prev, 25 (5), 1559-1566  \nIntroduction  \nThe landscape of cancer treatment has dramatically evolved over recent decades, focusing on leveraging immune checkpoint modulation to enhance the body’s natural defense against cancerous cells [1] . Central to this approach is the programmed death-ligand 1 (PD-L1), a pivotal modulator that facilitates tumor cells in evading the immune response. PD-L1, present in various cell types, including tumor cells, binds to the programmed cell death protein 1 (PD-1) on immune cells, inhibiting T-cell mediated immunity and aiding tumor survival. Grasping the nuances of PD-L1 expression is vital for tailoring cancer therapy, as it can offer insights into tumor-immune interactions and inform the design of effective treatments. Recent findings highlight that PD-L1 expression isnot limited to the tumor environment. Circulating tumor cells (CTCs), as cancer cells detach from the main tumor mass and enter the bloodstream, also express PD-L1 [2] . As precursors to cancer metastasis, CTCs serve as real-time  \nindicators of disease progression, therapeutic resistance, and potential relapse. Notably, in breast cancer, PD-L1 expression in CTCs correlates with disease severity and prognosis, underscoring PD-L1’s significance in cancer development and treatment response.  \nHowever, the relationship between PD-L1 expression, CTCs, and the effectiveness of treatments like radiotherapy, especially concerning locally advanced breast cancer, remains to be fully explored. Radiotherapy is fundamental in treating breast cancer, but its effects on PD-L1 expression and subsequent tumor behavior are not yet thoroughly understood [3]. Deciphering this relationship may offer pivotal therapeutic insights, facilitating personalized treatment approaches that enhance patient outcomes.  \nHence, this study seeks to investigate the impact of neoadjuvant radiotherapy on PD-L1 expression in tumor tissues and CTCs in","cbCainM9506FiQYt","https://ap.wps.com/l/cbCainM9506FiQYt","pdf",1016650,"English","# Abstract\n# Introduction\n# Materials and Methods\n## Patient Selection\n## Sample Collection\n# Results\n# Conclusion","[{\"question\":\"What was the primary aim of this exploratory study?\",\"answer\":\"To determine whether neoadjuvant radiotherapy influences PD-L1 expression in tumor tissues and circulating tumor cells in patients with inoperable locally advanced breast cancer.\"},{\"question\":\"How were CTCs isolated and PD-L1 measured?\",\"answer\":\"CTCs were enriched using magnetic beads, followed by RT-PCR analysis to assess PD-L1 expression.\"},{\"question\":\"Did neoadjuvant radiotherapy significantly change PD-L1 expression?\",\"answer\":\"No. The study found no significant alterations in PD-L1 expression in either tumor tissues or CTCs during radiotherapy.\"},{\"question\":\"What association was observed with RECIST?\",\"answer\":\"PD-L1 expression in tumor tissue before treatment was significantly associated with RECIST criteria.\"}]","Investigating Radiotherapy Effects on PD-L1 Expression in Circulating Tumor Cells - An Exploratory Study | PDF",1790042981,[149,153,157,161],{"page_no":8,"url":150,"width":151,"height":152},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/025e59966732718a38ce3505508383fa.webp",983,1390,{"page_no":14,"url":154,"width":155,"height":156},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f37960714d7f51928819674ba38f7d0f.webp",982,1388,{"page_no":81,"url":158,"width":159,"height":160},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/784e53d79c5e88746b9c42ef88bb7a58.webp",981,1387,{"page_no":19,"url":162,"width":163,"height":164},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ed3e9c02df1fdf523cf53ffec4e9f24e.webp",980,1385]